WOLVERINE TRADING, LLC - MYMD PHARMACEUTICALS INC ownership

MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 42 filers reported holding MYMD PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of MYMD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$39,420
+131300.0%
27,000
+53.4%
0.00%
Q1 2023$30
-28.6%
17,601
-50.8%
0.00%
Q4 2022$42
-100.0%
35,809
-68.8%
0.00%
Q3 2022$292,000
+165.5%
114,656
+360.2%
0.00%
Q1 2022$110,000
-39.6%
24,916
-25.1%
0.00%
Q4 2021$182,000
-16.5%
33,258
+9.9%
0.00%
Q3 2021$218,00030,2530.00%
Other shareholders
MYMD PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Shay Capital LLC 309,178$671,0000.14%
Taylor & Morgan Wealth Management, LLC 17,086$37,0000.04%
Ikarian Capital, LLC 81,089$176,0000.03%
Corundum Group, Inc. 19,600$43,0000.03%
M Holdings Securities, Inc. 70,909$154,0000.02%
Praetorian Wealth Management, Inc. 15,000$32,0000.01%
Western Wealth Management, LLC 27,050$115,0000.01%
Mirae Asset Global Investments Co., Ltd. 1,073,765$2,330,0000.01%
Virtu Financial LLC 16,063$35,0000.00%
SeaCrest Wealth Management, LLC 6,800$15,0000.00%
View complete list of MYMD PHARMACEUTICALS INC shareholders